✦ LIBER ✦

Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study

✍ Scribed by Nicolle, L.E.; Capuano, G.; Ways, K.; Usiskin, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and Pharmacodynamics of

✍ Devineni, Damayanthi; Curtin, Christopher R.; Polidori, David; Gutierrez, Maria 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 605 KB

Canagliflozin (CANA), a Sodium Glucose C

✍ Yale, Jean-Francois; Bakris, George; Xi, Liwen; Figueroa, Kate; Wajs, Ewa; Usisk 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 79 KB

Efficacy and Safety of Canagliflozin, a

✍ Leiter, Lawrence A.; Cefalu, William T.; Niskanen, Leo; Xie, John; Millington, D 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 62 KB

First human dose-escalation study with r

✍ Anita Kapur, Robin O’Connor-Semmes, Elizabeth K Hussey… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 270 KB

Evaluation of vulvovaginal symptoms and

✍ Nyirjesy, Paul; Zhao, Yue; Ways, Kirk; Usiskin, Keith 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 129 KB

Efficacy and safety of twice-daily treat

✍ Qiu, Rong; Capuano, George; Meininger, Gary 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 162 KB